The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
OBJECTIVES: This study sought to compare the 1-year safety and efficacy of Cypher Select or Cypher Select Plus (Cordis Corporation, Bridgewater, New Jersey) sirolimus-eluting stents (SES) with the treatment of bare-metal stents (BMS) and drug-eluting stent (DES) in-stent restenosis (ISR) in nonselec...
Main Authors: | Abizaid, A, Costa, JR, Banning, A, Bartorelli, A, Dzavik, V, Ellis, S, Gao, R, Holmes, DR, Jeong, M, Legrand, V, Neumann, F, Nyakern, M, Orlick, A, Spaulding, C, Worthley, S, Urban, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry.
by: Hong, Y, et al.
Published: (2011) -
One-year clinical outcomes after sirolimus-eluting coronary stent implantation for acute myocardial infarction in the worldwide e-SELECT registry
by: Worthley, S, et al.
Published: (2012) -
One-year clinical outcomes after sirolimus-eluting coronary stent implantation for acute myocardial infarction in the worldwide e-SELECT registry.
by: Worthley, S, et al.
Published: (2012) -
Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry.
by: Urban, P, et al.
Published: (2011) -
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry.
by: Cuculi, F, et al.
Published: (2011)